Page last updated: 2024-11-04

sarpogrelate and Hypertension

sarpogrelate has been researched along with Hypertension in 1 studies

sarpogrelate: structure given in first source

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research Excerpts

ExcerptRelevanceReference
"Sarpogrelate and quinapril were administered orally for 12 weeks and body and heart weights, systolic blood pressure and the relationships between heart weight and systolic blood pressure were determined."1.31Effects of chronic administration of sarpogrelate on systolic blood pressure of spontaneously hypertensive rats: comparison with quinapril. ( Hattori, K; Mitomi, A; Nagatomo, T; Nakamura, T; Nakazawa, M; Ohnuki, T; Rashid, M; Setoguchi, Y; Watanabe, K, 2002)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Setoguchi, Y1
Ohnuki, T1
Rashid, M1
Nakamura, T1
Hattori, K1
Nagatomo, T1
Watanabe, K1
Mitomi, A1
Nakazawa, M1

Other Studies

1 other study available for sarpogrelate and Hypertension

ArticleYear
Effects of chronic administration of sarpogrelate on systolic blood pressure of spontaneously hypertensive rats: comparison with quinapril.
    Pharmacology, 2002, Volume: 64, Issue:2

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Hypertension; Isoqui

2002